Eric Veys
About
In The Last Decade
Eric Veys
178 papers receiving 9.0k citations
Hit Papers
Peers
Comparison fields: 5 of 121
- Rheumatology 6.9k
- Immunology 3.1k
- Hematology 2.2k
- Surgery 1.3k
- Genetics 1.1k
Countries citing papers authored by Eric Veys
This map shows the geographic impact of Eric Veys's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric Veys with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric Veys more than expected).
Fields of papers citing papers by Eric Veys
This network shows the impact of papers produced by Eric Veys. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric Veys. The network helps show where Eric Veys may publish in the future.
Co-authorship network of co-authors of Eric Veys
This figure shows the co-authorship network connecting the top 25 collaborators of Eric Veys. A scholar is included among the top collaborators of Eric Veys based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric Veys. Eric Veys is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | A prospective study of alginate seeded with mature allogenic human chondrocytes in the treatment of articular cartilage defects | 3 |
| 2 | Anti-tumour necrosis factor alpha-induced apoptosis contributes to the induction of autoantibodies but not the downregulation of synovial inflammatory infiltration in spondyloarthritis | 1 |
| 3 | Potent anti-inflammatory, fully dissociative compound for glucocorticoid receptor-mediated gene regulation | 2 |
| 4 | Increased systemic and local expression of toll-like receptor 2 and 4 in spondyloarthropathy is downmodulated by tumour necrosis factor alpha blockade | 4 |
| 5 | IgM anti-dsDNA autoantibodies are the main antinuclear reactivity induced by infliximab but not etanercept treatment in vivo: Biological and clinical implications | 3 |
| 6 | Synovial intracellular citrullinated proteins colocalizing with peptidyl arginine deiminase are pathophysiologically relevant antigenic determinants of rheumatoid arthritis-specific humoral autoimmunity | 1 |
| 7 | Preliminary evidence for a retardation of structural damage in patients with ankylosing spondylitis continuously treated with infliximab for 4 years | 1 |
| 8 | Short and long term synovial immunumodulation by etanercept in spondyloarthropathy | 1 |
| 9 | Identification of synovial biomarkers of response to treatment in spondyloarthropathy | 1 |
| 10 | Rheumatoid factor and anti-citrullinated peptide antibodies in rheumatoid arthritis: Diagnostic value and association with radiological progression | 1 |
| 11 | 49 | |
| 12 | Is expression of intracellular citrullinated proteins in synovial tissue specific for rheumatoid arthritis? Comment on the article by Baeten et al - Reply. | 2 |
| 13 | Influence of polysulphated polysaccharides and hydrocortisone on the extracellular matrix metabolism of human articular chondrocytes in vitro. | 35 |
| 14 | T cell cytokines in gut mucosa of patients with spondyloarthropathy reflect immune alterations in Crohn's disease | 3 |
| 15 | Gastrointestinal tract and rheumatic disease | 1 |
| 16 | Clinical aspects of enterogenic arthropathies | 1 |
| 17 | 2nd Conference on spondylarthropathies and the gut, Gent, Belgium, 1-2 July 1993 | 2 |
| 18 | Destructive hip lesions in seronegative spondyloarthropathies: relation to gut inflammation. | 13 |
| 19 | 26 | |
| 20 | 7 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.